AmphiStar has secured €6 million in funding from ECBF, Qbic III, and FFTF to accelerate the industrialization of its innovative biosurfactants produced from food waste, positioning itself for significant market growth.
Information on the Target
AmphiStar, based in Ghent, Belgium, is an innovative start-up specializing in the production of biosurfactants derived from food waste and side streams of the agri-food industry. Founded in 2021, AmphiStar is a spin-off from Ghent University and the Bio Base Europe Pilot Plant, leveraging over 15 years of advanced research and technical expertise. The company aims to disrupt the traditional surfactant market by offering sustainable, high-performance biosurfactants that are environmentally friendly and biocompatible.
With an eye towards expansion, AmphiStar has recently attracted significant funding, allowing for the acceleration of product industrialization and team development. The leadership team is bolstered by the appointment of Pierre-Franck Valentin as CEO, who will guide the company's strategic direction as it prepares for market launch and growth.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Belgium
The surfactant industry plays a critical role in various sectors, including personal care, cleaning agents, agrochemicals, and food products, contributing to an annual global production of over 20 million
Similar Deals
European Circular Bioeconomy Fund (ECBF) → AmphiStar
2023
Pace Ventures → ChemFinity Technologies
2025
Loggerhead Ventures, Sporos Platform, Moro Global, imec.istart → Mobito
2025
TGFS Technologiegründerfonds Sachsen, GIMIC Ventures, bm-t, Chemovator → Zepta
2025
European Circular Bioeconomy Fund, Qbic III, Flanders Future Tech Fund
invested in
AmphiStar
in 2024
in a Seed Stage deal
Disclosed details
Transaction Size: $6M